🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a bioequivalence trial to evaluate the bioequivalence of Myrin P Fo...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-07
Trial ID
NCT01399788
Treatments Being Tested
This is a single dose, open-label, randomised, two period, two-way cross-ov...
Status
Completed
Location
CROSS Research S.A., Phase I Unit,
Start Date
2018-07-23
Trial ID
NCT04678076
Treatments Being Tested
According to the relevant provisions of bioequivalence test, ezetimibe Tabl...
Status
Unknown
Location
Phase Ⅰ Clinical Research Center
Start Date
2021-03-13
Trial ID
NCT04814589
Treatments Being Tested
The goal of this study is to learn what happens to enlicitide (MK-0616) in ...
Status
Completed
Location
Celerion ( Site 0001)
Start Date
2026-03-23
Trial ID
NCT07481708
Treatments Being Tested
Compare the pharmacokinetic characteristics and safety between CKD-333 tabl...
Status
Completed
Location
Seoul Saint Mary's Hospital
Start Date
2018-08-08
Trial ID
NCT03659149
Treatments Being Tested
The aims of this study are to compare the blood levels achieved with a new ...
Status
Completed
Location
Research Site
Start Date
2009-05
Trial ID
NCT00908934
The overall aim of this clinical study is to investigate the ability of der...
Status
Completed
Location
Medical University Graz
Start Date
2014-01
Trial ID
NCT02711267
The purpose of this study is to assess the bioavailability of four experime...
Status
Completed
Location
Mds Pharma Services (Us) Inc.
Start Date
2009-05
Trial ID
NCT00901498
Treatments Being Tested
This study aims to establish bioequivalence between two tablet formulations...
Status
Completed
Location
Covance
Start Date
2015-03
Trial ID
NCT02371707
Treatments Being Tested
This study will evaluate the bioavailability, palatability, safety and tole...
Status
Completed
Location
Quotient Clinical Ltd, Clinical Research Unit
Start Date
2019-06-06
Trial ID
NCT03961100
Treatments Being Tested